Web Research

Web Research — What the Internet Knows

Figures converted from KRW at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

The Bottom Line from the Web

The filings show a Korean semiconductor test-handler maker whose FY2025 revenue nearly doubled. The web reveals the part the filings underplay: control of Mirae Corporation flipped in July 2023 to a holding chain anchored by Nexturn Bioscience / Nexturn Roll Korea, with intermediate stakes routed through KOSDAQ-listed talent agency Studio Santa Claus Entertainment and ROA Holdings (chairman On Seong-jun, listed as the highest-paid "non-operational" executive), and that on 2026-01-04 Nexturn Roll Korea announced it would inject approximately $4.5 million of additional funding into Mirae. Pair that with the issuer's own disclosure that 56.5% of FY2025 revenue came from a single Chinese counterparty (YILINING / Yiling Trading) — and the bottom-line picture is a small-cap precision-equipment business riding a Chinese-memory order surge under the control of an entertainment-and-biotech holding pyramid.

What Matters Most

Ten findings, ranked by how much they would change an investor's view of Mirae Corporation today.

1. Controlling shareholder is a non-industrial holding chain — and just injected more capital

On 2026-01-04 Mirae disclosed that it expects to receive approximately $4.5 million in funding from Nexturn Roll Korea Co., Ltd. (per Marketscreener news feed for 025560 — https://www.marketscreener.com/quote/stock/MIRAE-CORPORATION-6494937/). Control of Mirae passed from Gwangrim to Nexturn Bioscience in July 2023; specialist queries trace the chain as Nexturn Roll Korea (~32.31%, mostly via CB Series 8 and 9 conversions) → Studio Santa Claus Entertainment (KOSDAQ:204630, formerly Huayi Brothers Korea / Fleet Entertainment, ~18%) → ROA Holdings (~27%, chairman On Seong-jun / 온성준). That a loss-making entertainment-and-biotech holding pyramid is now the controlling shareholder of a 1983-vintage semiconductor-equipment maker is the single most consequential governance fact external sources surface.

2. Customer concentration is severe and geographically/politically loaded

Forensic, Warren, Industry and Historian specialist queries all flag the same fact: a single Chinese counterparty accounted for 56.5% of FY2025 revenue. The counterparty is identified in two single-supply DART contract disclosures as Yiling Trading (YILINING PRECISION), announced on the Marketscreener feed for 2025-09-08 as "Mirae Signs Two Semiconductor Inspection Equipment Supply Contracts with China's Yiling Trading." English-language sources could not establish Yilining's ultimate beneficial owner, leaving open whether the equipment is flowing downstream to a US Entity-Listed counterparty such as CXMT (added Dec 2024) or YMTC (added Dec 2022).

3. Top-line surged 97.68% but margins compressed — operating leverage went the wrong way

EMIS (https://www.emis.com/php/company-profile/KR/Mirae_Corporation_en_1651085.html) summarises the FY2025 YoY change set:

Net sales almost doubled, yet EBITDA shrank −5.37% and operating-profit margin fell 16.18 percentage points. The classic interpretation — Mirae is shipping more equipment at thinner mix and worse pricing — is not contradicted by anything else in the search results.

4. Sustained DART-filed order book, but average ticket size is small

The Marketscreener news ticker (https://www.marketscreener.com/quote/stock/MIRAE-CORPORATION-6494937/) records a heavy 2025–26 cadence of single-supply contract DART filings, summarised in the timeline table further down. Total disclosed order flow across the last twelve months is in the $35–41 million range, against FY2025 revenue of approximately $35 million — a credible forward-bookings proxy that suggests revenue momentum is not yet rolling over.

5. Lagging peer set despite the recent rally

Yahoo Finance places Mirae's market cap at approximately $81 million (close 2026-05-21, $18.22 per share). Marketscreener's peer table shows 5-day +26.32%, 1-year +169.11%, 3-year −61.52%. The peer ATE/handler group (KLA, Advantest, Cohu, Teradyne) rallied +130–700% over the same 3-year window. The +94% one-month surge in April–May 2026 that the technicals specialist flagged is closer to peer catch-up than to a fundamental re-rating; no English source attributes a specific catalyst.

6. Equity-restructuring activity that disqualifies historical share-count comparisons

Investing.com split history (https://www.investing.com/equities/mirae-historical-data-splits) records a 16:1 reverse stock split on 2025-06-27 (0.0625-for-1) and a scheduled 5-for-1 forward split on 2026-07-27. The reverse split is the standard tell of either KOSDAQ minimum-price compliance or a clean-up after heavy CB-driven dilution. Any per-share or share-count series sourced from before 2025-06-27 must be adjusted before it can be compared to post-split data; few third-party feeds do this correctly for KOSDAQ small-caps.

7. FY2023 was a near-collapse — and the financial statements were restated

Specialist queries flag a FY2023 revenue collapse of roughly −61% and a net loss in the $24 million range under former CEO Sun Jong-eob, coinciding with the broader memory-test downturn and with the July-2023 control flip. Forensic specialist queries (Korean-language "재무제표 정정") indicate the FY2023 financial statements were restated, but no English-source reconciliation was found. The combination of an inflection-low FY, a CEO change, a controlling-shareholder change, and a restatement in a single 12-month window is the kind of event cluster that warrants reading the Korean DART filings directly.

8. The FY2024 approximately $25 million PP&E spend has no disclosed counterparty in English sources

Forensic specialist query "FY2024 capex approximately $25 million PP&E land building facility purchase counterparty" returned no English-source identification of who Mirae bought the land/building/facility from. With control resting in a related-party holding chain, the natural follow-up question is whether the seller was an arm's-length party or another entity within the Nexturn / ROA / Studio Santa Claus pyramid.

9. No analyst coverage; no governance score; thin insider-transaction data

Investing.com, AdvFN and Yahoo all surface placeholder pages for "analyst ratings and price targets for 025560" but no actual coverage is published. ISS Governance QualityScore is N/A. Simply Wall St ownership page reads: "Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months" (https://simplywall.st/stocks/kr/semiconductors/kose-a025560/mirae-shares/ownership). For a stock that has rallied +169% over a year, the absence of any sell-side or governance-watchdog scrutiny is itself a finding — the rally is happening in a coverage vacuum.

10. Heavy noise from unrelated "Mirae" entities — most lawsuit/regulatory hits do not apply

Web searches for "Mirae" return dominant results for Mirae Asset Securities (KRX:006800), Mirae Asset Global Investments, Mirae Industry (civil-engineering, Siheung-based), Mirae IT, Mirae Eng (oil & gas) and a US 485BPOS SEC filing for a Mirae mutual fund. All flagged regulatory/litigation hits — Ryze v. Mirae Asset Securities arbitration (July 2023), PS Financial $138 million fraud (Jan 2025), SEC/FINRA BrokerCheck items — belong to the financial-services group, not to Mirae Corporation 025560. A reader who relies on a name-only news scrape will be badly misled on litigation exposure.

Recent News Timeline

The cluster of high-significance items in late 2025 / early 2026 — the Yiling Trading contracts, the $9.7M and $6.9M orders, then the Nexturn funding round — is the spine of the post-control-flip recovery narrative. The cadence of small DART-filed single-supply contracts in March 2026 is the secondary tape that the market appears to be trading.

What the Specialists Asked

Thirty-three specialist questions were issued across nine specialist queues. Below: the questions, the synthesised answer, the source signal and a confidence note. Questions where English-language sources returned no primary evidence are flagged explicitly — those are the gaps the Korean-language DART filings would need to close.

Governance and People Signals

The official roster from Yahoo Finance (https://finance.yahoo.com/quote/025560.KS/profile/) and the DART entity record:

Three patterns stand out:

• ISS Governance QualityScore is N/A. No independent governance scoring exists. A reader cannot triangulate board quality through the usual screens.
• Highest-paid executive is "non-operational." Specialist queries flag On Seong-jun (chairman of ROA Holdings, up the control chain) as receiving the largest compensation despite a non-operational title. The DART executive-pay disclosure is the primary source — English coverage does not reproduce the number.
• No insider-transaction signal. Simply Wall St explicitly reports "Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months." For a stock up +169% in twelve months, the inability to verify whether insiders are taking liquidity is the relevant gap, not the absence of a flagged sale.

The Ryze v. Mirae Asset Securities arbitration (July 2023), PS Financial $138 million fraud (January 2025), and various SEC/FINRA BrokerCheck items returned by name-only searches refer to Mirae Asset Securities (KRX:006800) — a separate Park Hyeon-joo group company — and do not apply to Mirae Corporation 025560.

Industry Context

The Industry tab already covers the structural primer. The external evidence that newly bears on Mirae specifically:

• Global semiconductor-equipment market is sized at USD 115–138 billion in 2025–26, growing 9–10% CAGR to USD 220–330 billion by 2031–35 per Coherent Market Insights and Mordor Intelligence — but these forecasts are dominated by front-end and lithography (ASML, Applied, Lam, KLA, Tokyo Electron). Mirae's back-end test-handler and SMT mounter segment is a much smaller slice and is not separately sized in the returned pages.
• HBM is the dominant industry catalyst through 2027 — 2 nm mass production starting late 2025, 1.6 nm starting late 2026, HBM4 ramping — but the named HBM-test winners are Hanmi Semiconductor and Techwing, not Mirae. No source ties Mirae's product roadmap to HBM known-good-die test flows. This is the largest structural risk if it remains true.
• SEAJ forecasts Japanese semiconductor equipment sales at approximately $35 billion in fiscal 2026 (¥5.35 trillion at approximately 150 JPY/USD — kantenna.com). Korean small-cap equipment makers are positioned as second-tier suppliers into both Korean memory (SK Hynix, Samsung) and Chinese memory; recent disclosed orders suggest Mirae's recent revenue mix tilts more Chinese than Korean.
• US BIS back-end export-control expansion is the most-watched 2026 rule change. Back-end test equipment is largely exempt today; if controls extend, Mirae's 56.5%-of-revenue Chinese counterparty is the direct exposure.